Profile data is unavailable for this security.
About the company
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the production, research, development and sale of chemical medicine and Chinese patent drugs. The Company's chemical medicine products mainly include Shapuaisi Bendazac Lysine Eye Drops, infusion products and cefixime products. The Company's Chinese patent drugs include kidney tonifying and nerve soothing products, such as Sizi Tianjing Capsules and Compound Gaoshan Hongjingtian Solution. The Company distributes its products in domestic market.
- Revenue in CNY (TTM)505.58m
- Net income in CNY-84.79m
- Incorporated2000
- Employees1.39k
- LocationZhejiang Shapuaisi Pharmaceutical Co LtdLumianjin BridgeChengbei Road, Pinghu CityJIAXING 314200ChinaCHN
- Phone+86 57 385021168
- Fax+86 57 385076188
- Websitehttp://www.zjspas.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ningbo Menovo Pharmaceutical Co Ltd | 1.24bn | 20.30m | 3.07bn | 2.35k | 161.26 | 1.41 | -- | 2.48 | 0.087 | 0.087 | 5.70 | 9.92 | 0.267 | 1.18 | 4.91 | 525,730.80 | 0.5164 | 4.94 | 0.7951 | 7.83 | 29.01 | 35.39 | 1.93 | 13.71 | 0.7203 | 4.44 | 0.4199 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.34bn | 138.87m | 3.09bn | 1.30k | 22.22 | 2.20 | -- | 1.32 | 0.4865 | 0.4865 | 8.18 | 4.92 | 0.8003 | 3.34 | 4.76 | 1,801,909.00 | 5.42 | 5.93 | 11.26 | 11.25 | 49.14 | 53.26 | 6.78 | 7.82 | 0.7061 | 6.61 | 0.3593 | 30.64 | 11.20 | 16.36 | -4.50 | 12.91 | 9.35 | 13.97 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.97bn | 89.38m | 3.14bn | 2.35k | 36.11 | 2.00 | -- | 1.60 | 0.1515 | 0.1515 | 3.39 | 2.74 | 0.5571 | 2.93 | 2.06 | 836,256.80 | 2.67 | 0.272 | 5.80 | 0.4981 | 27.64 | 27.97 | 4.79 | 0.5501 | 0.8146 | 2.65 | 0.3911 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 505.58m | -84.79m | 3.20bn | 1.39k | -- | 1.90 | -- | 6.32 | -0.2245 | -0.2245 | 1.34 | 4.44 | 0.2408 | 2.86 | 13.81 | 365,039.00 | -3.93 | -0.7573 | -4.52 | -0.8713 | 50.29 | 58.02 | -16.32 | -2.45 | 1.04 | -- | 0.1236 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
| GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.40bn | -235.62m | 3.23bn | 5.51k | -- | 1.22 | -- | 1.35 | -0.2975 | -0.2975 | 3.03 | 3.34 | 0.5288 | 1.52 | 13.04 | 435,209.10 | -5.39 | 0.8648 | -6.97 | 1.18 | 61.81 | 74.87 | -10.19 | 1.45 | 1.36 | -9.98 | 0.2375 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
Data as of Nov 14 2024. Currency figures normalised to Zhejiang Shapuaisi Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 22.20k | 0.01% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2024 | 6.10k | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 4.20k | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 1.90k | 0.00% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 1.40k | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
